Details for 2021191931

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON HAUTKREBS DURCH VERABREICHUNG EINES PD-1-INHIBITORS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021191931

EP Publication Number

3932951

E-Number

1536269

Language

PCT Number

Publication Date

05.01.2022 A

07.12.2022 B1

Registration Date

07.12.2022

AT Publication Date

15.12.2022

Application Date

12.05.2017

Registration Number

Priorities

13.05.2016

201662335743 P

23.05.2016

201662340142 P

10.06.2016

201662348546 P

15.06.2016

201662350305 P

21.07.2016

201662364920 P

12.08.2016

201662374020 P

27.01.2017

201762451274 P

IPC

C07K 16/28 20060101AFI20211201BHEP

Maximum Duration of Protection

12.05.2037

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

LOWY, Israel New York 10591US

FURY, Matthew, G. New York 10591US

Information about Fees